Skip to main content

Advertisement

Log in

Effect of polyamidoamine (PAMAM) dendrimers on the in vitro release of water-insoluble nifedipine from aqueous gels

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The objective of this study was to determine the effect of ethylenediamine core PAMAM dendrimers, on the release of nifedipine suspended in aqueous gels and to correlate release to the increase in solubility afforded by the dendrimers. Drug release from aqueous 5% HPMC gels containing nifedipine (2% wt/vol) through 0.2-μm membranes was measured using Enhancer cells and 50% ethanolic solution as the receptor medium. The release from gels containing PAMAM G-3 and G-5 (0.25%–1% wt/vol) was compared with gels containing the cosolvent isopropyl alcohol (10%–80% vol/vol). PAMAM dendrimers significantly increased the solubility of nifedipine. This caused a significant increase in the release rate of nifedipine from the gel suspensions. The increase in drug release depended on the concentration and generation size of the dendrimers added. For higher generations (G-5) lower concentrations were needed to obtain equivalent increases in release. Although the increase in solubility and release was not as high as from gels containing high concentrations of the cosolvent isopropyl alcohol, the dendrimers prevented the recrystallization of the drug that was observed when the gels containing isopropyl alcohol were left open.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ali SL. Nifedipine. In: Florey K, ed.Analytical Profiles of Drug Substances. New York, NY: Academic Press; 1989:223–228.

    Google Scholar 

  2. Perrotti P, Antropoli C, Molino D, De Stefano G, Antropoli M. Conservative treatment of acute thrombosed external hemorrhoids with topical nifedipine.Dis Col Rec. 2001;44:405–409.

    Article  CAS  Google Scholar 

  3. Ezri T, Susmallian S. Topical nifedipine vs topical glyceryl trinitrate for treatment of chronic anal fissure.Dis Col Rec. 2003;46: 805–808.

    Article  Google Scholar 

  4. Israel A. Topical gel for the treatment of refractory leg ulcer.Int J Pharm Comp. 2003;7:176–178.

    Google Scholar 

  5. Merenstein D, Rosenbaum D. Is topical nifedipine effective for chronic anal fissures?.J Fam Prac. 2003;52:190–192.

    Google Scholar 

  6. Slawson D. Topical nifedipine plus lidocaine gel effective for anal fissures.Am Fam Physiol. 2003;67:1781.

    Google Scholar 

  7. Segarra J, Santafe J, Garrido M, Martinez de Ibarreta MJ. The topical application of verapamil and nifedipine lowers intraocular pressure in conscious rabbits.Gen Pharmacol. 1993;24:1163–1171.

    CAS  Google Scholar 

  8. Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: theory and in vitro experimental measurement.J AIChE. 1975;21:985–996.

    Article  CAS  Google Scholar 

  9. Kondo S, Mizuno T, Sugimoto I. Effects of penetration enhancers on percutaneous absorption of nifedipine. Comparison between DDET and Azone.J Pharmacobiodyn. 1988;11:88–95.

    CAS  Google Scholar 

  10. Chauhan AS, Sridevi S, Chalasani KB, et al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.J Cont Rel. 2003;90:335–343.

    Article  CAS  Google Scholar 

  11. El-Sayed M, Kiani MF, Naimark MD, Hikal AH, Gandhehari H. Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium.Pharm Res. 2001;18:23–28.

    Article  CAS  Google Scholar 

  12. El-Sayed M, Ginski M, Rhodes C, Ghandehari H. Transepithelial transport of poly (amidoamine) dendrimers across Caco-2 cell monolayers.J Cont Rel. 2002;8:355–365.

    Article  Google Scholar 

  13. Kolhe P, Misra E, Kannan RM, Kanna S, Lieh-Lai M. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.Int J Pharm. 2003;259:143–160.

    Article  CAS  Google Scholar 

  14. Wang Z, Itoh Y, Hosaka Y, et al. Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamidoamine dendrimer.J. Biosci Bioeng. 2003;95:541–543.

    CAS  Google Scholar 

  15. Purohit G, Sakthivel T, Florence AT. The interaction of cationic dendrons with albumin and their diffusion through cellulose membranes.Int J Pharm. 2003;254:37–41.

    Article  CAS  Google Scholar 

  16. Vandamme TF, Brobeck L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine and tropicamide.J Cont Rel. 2005;102:23–38.

    Article  CAS  Google Scholar 

  17. Boje KM, Sak M, Fung HL. Complexation of nifedipine with substituted phenolic ligands.Pharm Res. 1988;5:655–659.

    Article  CAS  Google Scholar 

  18. Vippagunta SR, Maul KA, Tallavajhala S, Grant DJW. Solid-state characterization of nifedipine solid dispersions.Int J Pharm. 2002;236:111–123.

    Article  CAS  Google Scholar 

  19. Devarakonda B, Hill RA, De Villiers MM. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine.Int J Pharm. 2004;284:133–140.

    Article  CAS  Google Scholar 

  20. Higuchi T, Conners KA. Phase-solubility techniques. In: Reilly CN, ed.Advances in analytical chemistry and instrumentation. New York: John Wiley; 1965:117–212.

    Google Scholar 

  21. Jain NK, Patel VV, Taneja LN. Hydrotropic solubilation of nifedipine.Pharmazie 1988;43(3):194–196.

    CAS  Google Scholar 

  22. Loftsson T, Fridriksdottir H, Olafsdottir B, Gudmundson O. Solubilization and stabilization of drugs through cyclodextrin complexation.Acta Pharm Nord. 1991;3:215–217.

    CAS  Google Scholar 

  23. Larrucea E, Arellano A, Santoyo S, Ygartua P. Interaction of tenoxicam with cyclodextrins and its influence on the in vitro percutaneous penetration of the drug.Drug Dev Ind Pharm. 2001;27:251–260.

    Article  CAS  Google Scholar 

  24. Esfand R, Tomalia DA.Dendrimers and other dendritic polymers. New York: John Wiley; 2001:589–604.

    Google Scholar 

  25. Campbell PS, Chandrasekaran SKUS. Dosage for administrating and percutaneous absorption enhancer. US patent 4379454. April 13, 1983.

  26. Berner B, Mazzenga GC, Otter JH, Steffens RJ, Juang RH, Ebert CD. Ethanol:water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin.J Pharm Sci. 1989;78:402–407.

    Article  CAS  Google Scholar 

  27. Caira MR, Robbertse Y, Bergh JJ, Song M, De Villiers MM. Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine.J Pharm Sci. 2003;92:2519–2533.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melgardt M. de Villiers.

Additional information

Published: October 24, 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Devarakonda, B., Li, N. & de Villiers, M.M. Effect of polyamidoamine (PAMAM) dendrimers on the in vitro release of water-insoluble nifedipine from aqueous gels. AAPS PharmSciTech 6, 63 (2005). https://doi.org/10.1208/pt060363

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt060363

Keywords

Navigation